Biobanks in Precision Medicine

Biobanks in Precision Medicine

Article in ‘The Hindu’ about biobanks and precision medicine.

  • Biobanks store biological samples (e.g., blood, DNA, tissues) with genetic data.
  • Large, diverse biobanks are essential for inclusive precision medicine.
  • Recent studies use biobanks to diagnose rare genetic disorders and develop new therapies.
  • Biobanks in India
    • 19 registered biobanks house diverse samples including cancer cell lines
    • Genome India program  sequenced 10,000 genomes to find treatments for rare diseases.
    • The Phenome India project collected 10,000 samples to predict cardio-metabolic diseases.
    • The PRaGeD mission (Mission program on Pediatric Rare Genetic Disorders) seeks to identify new genes for pediatric genetic disorders.

Phenome India – CSIR Health Cohort Knowledgebase (PI-CheCK) is an initiative by the Council of Scientific and Industrial Research (CSIR), launched in 2023. Objective: to develop India-specific risk prediction models for cardio-metabolic diseases including diabetes, liver diseases, and cardiac diseases.

  • Challenges with Biobank Regulations in India
    • Many countries have laws ensuring informed consent, privacy, and data protection; India lacks these.
    • India’s regulations are inconsistent and have gaps, particularly in participant consent and data handling.
    • Lack of transparency
  • Precision medicine – a medical model that uses a person’s genetic, environmental, and lifestyle information to guide medical decisions.
  • Precision medicine focuses on personalized healthcare, gaining traction since the  Human Genome Project.
  • Genomics plays a key role in diagnosing and treating cancers, chronic diseases, immunological, cardiovascular, and liver diseases.
  • Technologies like gene-editing and mRNA therapeutics are advancing precision medicine.
  • Precision Medicine in India
    • The Indian precision medicine market is growing at 16% CAGR, projected to be worth $5 billion by 2030.
    • Contributes 36% of the national bioeconomy alongside cancer therapies, gene editing, and biologics.
    • The  BioE3 policy includes developing precision therapeutics.

Source:  TH


What is the Cas9 protein that is often mentioned in the news?

[UPSC Civil Services Exam – 2019 Prelims]

(a) A molecular scissors used in targeted gene editing
(b) A biosensor used in the accurate detection of pathogens in patients
(c) A gene that makes plants pest-resistant
(d) A herbicidal substance synthesized in genetically modified crops

Answer: (a)


Practice Question

Consider the following statements regarding biobanks:

  1. Biobanks are repositories that store biological samples like blood, DNA, and tissues for research purposes.
  2. Large, diverse biobanks are essential for precision medicine to benefit all sections of society.
  3. Biobanks in India are well-regulated, with comprehensive laws ensuring informed consent and data protection.

Which of the above statements is/are correct?

 
 
 
 

Question 1 of 1

Leave a Reply

Your email address will not be published. Required fields are marked *